Our results identified a marginal cost-effective ratio ( mCER ) of $ 18835.00 per quality-adjusted life year ( QALY ) when mechanical thrombectomy is reserved as a treatment only for patients with no-to-minimal baseline disability as compared to those with any level of baseline disability .